ECUBLENS, SWITZERLAND--(Marketwire - Oct 22, 2012) - Symetis Inc., a private Swiss company developing new transcatheter aortic valve implantation (TAVI) systems, announced during the PCR London Valves ...
Lonza enters development and manufacturing agreement with Genmab A/S for a novel antibody drug conjugate (ADC), HuMax-TF TM • This agreement secures a development and cGMP manufacturing plan for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results